Document is current
Any future updates will be listed below
-
Authors
Bladé, Joan https://orcid.org/0000-0002-4563-3405
Beksac, Meral
Caers, Jo https://orcid.org/0000-0002-3175-1195
Jurczyszyn, Artur https://orcid.org/0000-0001-9796-8365
von Lilienfeld-Toal, Marie https://orcid.org/0000-0002-9756-3541
Moreau, Philippe
Rasche, Leo https://orcid.org/0000-0002-9536-9649
Rosiñol, Laura https://orcid.org/0000-0002-2534-9239
Usmani, Saad Z.
Zamagni, Elena
Richardson, Paul https://orcid.org/0000-0002-7426-8865
- License Information
-
More Information
Article History
Received: 8 July 2021
Revised: 26 November 2021
Accepted: 7 March 2022
First Online: 21 March 2022
Competing interests
: J.B. has received speaker/lecture honoraria from Janssen, Celgene/BMS, Amgen, Takeda, and Oncopeptides. M.B. has received speaker honoraria from Amgen, Oncopeptides, Janssen, Sanofi, and Takeda. Jo Caers has received research funding from Takeda and Janssen; and honoraria from Janssen, Amgen, BMS-Celgene, and Sanofi. A.J. has received honoraria from Janssen, BMS, Takeda, Sanofi, GSK, Karyopharm, Oncopeptides, and Amgen. M.v.L.-T. has received research funding from Celgene and Oncopeptides; and honoraria from BMS/Celgene, Oncopeptides, Janssen, GSK, and Takeda. Philippe Moreau has received honoraria from Janssen, Celgene, Amgen, AbbVie, Oncopeptides, and Sanofi. Leo Rasche has received honoraria from BMS/Celgene, Sanofi, GSK, Oncopeptides, and Janssen. Laura Rosiñol has received speaker honoraria from Janssen, Celgene, Amgen, Takeda, GSK, and Sanofi. S.Z.U. has received research funding and/or honoraria from Amgen, Celgene, Janssen, Takeda, BMS, Oncopeptides, and Sanofi. E.Z. has received honoraria from, and been an advisory board member for, Janssen, BMS, Takeda, Sanofi, GSK, Karyopharm, Oncopeptides, and Amgen. P.R. has received institutional research support from Oncopeptides, Celgene/BMS, Takeda, and Karyopharm. He has received honoraria for his role as an Advisory Committee member from Karyopharm, Oncopeptides, Celgene/BMS, Takeda, Janssen, Sanofi, Secura Bio, GSK, Regeneron, AstraZeneca, and Protocol Intelligence.
